Compile Data Set for Download or QSAR
Report error Found 227 Enz. Inhib. hit(s) with all data for entry = 10761
TargetTyrosine-protein kinase JAK3(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM100350(US8501944, 375 | US8501944, 372 | US9868729, Examp...)
Affinity DataIC50: 0.800nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM100350(US8501944, 375 | US8501944, 372 | US9868729, Examp...)
Affinity DataKd:  2.70nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM100348(US8501944, 374 | US8501944, 370 | US9868729, Examp...)
Affinity DataKd:  2.90nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM100349(US8501944, 371 | US9868729, Example 207 | US105330...)
Affinity DataKd:  3nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK2(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM100350(US8501944, 375 | US8501944, 372 | US9868729, Examp...)
Affinity DataIC50: 3.20nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK3(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM100351(US8501944, 376 | US8501944, 373 | US9868729, Examp...)
Affinity DataKd:  4.10nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM100350(US8501944, 375 | US8501944, 372 | US9868729, Examp...)
Affinity DataKd:  4.70nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365380(US9868729, Example 41 | US10533001, Example 41 | U...)
Affinity DataIC50: 5.5nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM100350(US8501944, 375 | US8501944, 372 | US9868729, Examp...)
Affinity DataIC50: 6.70nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM100348(US8501944, 374 | US8501944, 370 | US9868729, Examp...)
Affinity DataKd:  6.70nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM100349(US8501944, 371 | US9868729, Example 207 | US105330...)
Affinity DataKd:  11nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase JAK1(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM100351(US8501944, 376 | US8501944, 373 | US9868729, Examp...)
Affinity DataKd:  14nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM100350(US8501944, 375 | US8501944, 372 | US9868729, Examp...)
Affinity DataIC50: 15nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365497(US9868729, Example 213 | US10533001, Example 213 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365496(US9868729, Example 212 | US10533001, Example 212 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365500(US9868729, Example 216 | US10533001, Example 216 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365504(US9868729, Example 222 | US10533001, Example 222 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365506(US9868729, Example 225 | US10533001, Example 225 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365507(US9868729, Example 226 | US10533001, Example 226 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365482(US9868729, Example 198 | US10533001, Example 198 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365479(US9868729, Example 195 | US10533001, Example 195 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365480(4-(cyclopropylamino)-2-(4-(4-(methylsulfonyl)-1,4-...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365485(US9868729, Example 201 | US10533001, Example 201 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365483(US9868729, Example 199 | US10533001, Example 199 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365484(US9868729, Example 200 | US10533001, Example 200 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365489(US9868729, Example 205 | US10533001, Example 205 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365490(US9868729, Example 206 | US10533001, Example 206 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM565337(US11414410, Example 203)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365488(US9868729, Example 204 | US10533001, Example 204 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM100349(US8501944, 371 | US9868729, Example 207 | US105330...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365492(US9868729, Example 208 | US10533001, Example 208 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365529(US9868729, Example 250 | US10533001, Example 250 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365528(US9868729, Example 249 | US10533001, Example 249 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM565382(US11414410, Example 254)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365531(US9868729, Example 252 | US10533001, Example 252 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365532(US9868729, Example 253 | US10533001, Example 253 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365537(US9868729, Example 259 | US10533001, Example 259 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365538(US9868729, Example 260 | US10533001, Example 260 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365536(US9868729, Example 258 | US10533001, Example 258 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365541(US9868729, Example 263 | US10533001, Example 263 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365542(US9868729, Example 264 | US10533001, Example 264 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365512(US9868729, Example 231 | US10533001, Example 231 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365510(US9868729, Example 229 | US10533001, Example 229 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365517(US9868729, Example 237 | US10533001, Example 237 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365518(US9868729, Example 238 | US10533001, Example 238 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365515(US9868729, Example 235 | US10533001, Example 235 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365516(US9868729, Example 236 | US10533001, Example 236 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365521(US9868729, Example 241 | US10533001, Example 241 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365522(US9868729, Example 242 | US10533001, Example 242 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

TargetTyrosine-protein kinase SYK(Human)
Alexion Pharmaceuticals

US Patent
LigandPNGBDBM365519(US9868729, Example 239 | US10533001, Example 239 |...)
Affinity DataIC50: 55nMAssay Description:The kinase reaction is performed in a black U-bottom 96-well microtitre plate. The final reaction volume is 50 μL and contains a final concentra...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2022
Entry Details
US Patent

Displayed 1 to 50 (of 227 total ) | Next | Last >>
Jump to: